Polyfunctional CD8+ T cell responses induced by the 15mer peptide-loaded DC supported this peptide as the optimal epitope, but were less discriminatory among the 8-10mer, N and C terminal variants presented with or without DC.
Furthermore, besides the 177 bp band, the c.4988T>A/p.Met1663Lys and c.5072C>T/p.Thr1691Ile variants presented with a very weak wild-type band at 265 bp constituting 7%% and 17.5 % of the total amount of transcript, respectively (Fig. 2b).
Clinical hallmarks are prolonged fever, cytopenias, hepatosplenomegaly, and neurological symptoms, but atypical variants presenting with signs of chronic immunodeficiency are increasingly recognized.
All somatic variants presenting with VAFs lower than our very conservative threshold for minor cross-contamination (5-times 95% upper limit of contamination levels for each tumor sample, see above "Minor cross-contamination of DNA samples") were removed.
In histopathological analysis, young mice expressing either LRRK2 variant presented with transient vacuolization of striatal white fiber tracts accompanied by accumulation of microglial cells and astrogliosis, but inflammation resolved without permanent damage.
In non-diabetic participants (N = 3,819), carriers of PLA2 allele variant presenting with HbA1c > 5.5% (37 mmol/mol) showed higher relative risk of mortality with increasing HbA1c.
All of the allelic variants presented in association with RD involve potential SP1 transcription factor binding sites, either an SP1 site deletion or insertion of a VNTR (variable number of tandem repeat) motif containing multiple SP1 sites.
The main idea of the MaLTA approach is to cover all trancriptional and splicing variants presented in the sample with the minimum set of putative transcripts.
This dichotomous direction of effect is likely relevant to the phenotype in humans: individuals with loss-of-function variants leading to haploinsufficiency show ID with autistic features, while individuals with de novo dominant toxic variants present with ID, ataxia, and cerebellar atrophy.
While prior reports suggest the majority of LND variants present with problems related to uric acid, our results suggest the majority present with neurological problems.
Neuronopathic Gaucher disease variants present with brainstem, cerebellar, thalamic, cerebral cortical and substantia nigra involvement, but the degrees of involvement and affected regions vary among the patients (26– 26).
